Literature DB >> 25047578

Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo.

Xuan Zhang1, Jamee Bresee1, Gregg B Fields2, W Barry Edwards1.   

Abstract

The gelatinase members of the MMP family have consistently been associated with tumor invasiveness, which make them an attractive target for molecular imaging. We report new activatable proteolytic optical imaging agents that consist of triple-helical peptide (THP) conjugates, with high specificity to the gelatinases, bearing quenched cypate dyes. With quenching efficiencies up to 51%, the amplified fluorescence signal upon cypate3-THP hydrolysis by the gelatinases (kcat/KM values of 6.4×10(3) M(-1) s(-1) to 9.1×10(3) M(-1) s(-1) for MMP-2 and MMP-9, respectively) in mice bearing human fibrosarcoma xenografted tumors was monitored with fluorescence molecular tomography. There was significant fluorescence enhancement within the tumor and this enhancement was reduced by treatment with pan-MMP inhibitor, Ilomastat. These data, combined with the gelatinase substrate specificity observed in vitro, indicated the observed fluorescence at the site of the tumor was due to gelatinase mediated hydrolysis of cypate3-THP.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fluorescence molecular tomography (FMT); Gelatinase; Matrix metalloproteinase; Near-infrared (NIR) optical imaging; Triple-helical peptides

Mesh:

Substances:

Year:  2014        PMID: 25047578      PMCID: PMC4338581          DOI: 10.1016/j.bmcl.2014.06.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  34 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.

Authors:  J Upadhyay; B Shekarriz; J A Nemeth; Z Dong; G D Cummings; R Fridman; W Sakr; D J Grignon; M L Cher
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

3.  Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.

Authors:  H Kuniyasu; P Troncoso; D Johnston; C D Bucana; E Tahara; I J Fidler; C A Pettaway
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

4.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model.

Authors:  C Bremer; S Bredow; U Mahmood; R Weissleder; C H Tung
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

5.  MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions.

Authors:  Christian F Singer; Nicole Kronsteiner; Erika Marton; Marion Kubista; Kevin J Cullen; Kora Hirtenlehner; Michael Seifert; Ernst Kubista
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

6.  Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents.

Authors:  Samuel Achilefu; Hermo N Jimenez; Richard B Dorshow; Joseph E Bugaj; Elizabeth G Webb; R Randy Wilhelm; Raghavan Rajagopalan; Jill Johler; Jack L Erion
Journal:  J Med Chem       Date:  2002-05-09       Impact factor: 7.446

Review 7.  Chemical biology for understanding matrix metalloproteinase function.

Authors:  Anna Knapinska; Gregg B Fields
Journal:  Chembiochem       Date:  2012-08-30       Impact factor: 3.164

8.  Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides.

Authors:  J L Seltzer; K T Akers; H Weingarten; G A Grant; D W McCourt; A Z Eisen
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

9.  Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.

Authors:  Janelle L Lauer-Fields; Thilaka Sritharan; M Sharon Stack; Hideaki Nagase; Gregg B Fields
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

Review 10.  Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.

Authors:  H F Dvorak
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

View more
  3 in total

1.  Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.

Authors:  Reza Golestani; Mahmoud Razavian; Yunpeng Ye; Jiasheng Zhang; Jae-Joon Jung; Jakub Toczek; Kiran Gona; Hye-Yeong Kim; Jack A Elias; Chun Geun Lee; Robert J Homer; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2016-07-28       Impact factor: 10.057

2.  Dissecting MMP P10' and P11' subsite sequence preferences, utilizing a positional scanning, combinatorial triple-helical peptide library.

Authors:  Michal Tokmina-Roszyk; Gregg B Fields
Journal:  J Biol Chem       Date:  2018-09-05       Impact factor: 5.157

Review 3.  Regulation and involvement of matrix metalloproteinases in vascular diseases.

Authors:  Matthew Amin; Sathnur Pushpakumar; Nino Muradashvili; Sourav Kundu; Suresh C Tyagi; Utpal Sen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.